Literature DB >> 28295483

Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.

Marie Sinclair1,2, Anthony Schelleman1,3, Daljean Sandhu1, Peter W Angus1,2.   

Abstract

We report a case of dramatic systemic inflammatory symptoms and biochemical signs of inflammation related to multiple hepatic adenomas that completely resolved after cessation of the oral contraceptive pill (OCP) and associated adenoma regression. This represents a case of dramatic symptoms that resolved after estrogen withdrawal alone. (Hepatology 2017;66:989-991).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28295483     DOI： 10.1002/hep.29151

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


  3 in total

1.  Hepatic Adenomatosis: A Challenging Liver Disease.

Authors:  Diana Leite Gonçalves; José Pedro Leite; Rafael Silva; António Pedro Pissarra; Rui Caetano Oliveira; Dilva Silva
Journal:  GE Port J Gastroenterol       Date:  2019-08-08

Review 2.  Current Approaches in the Management of Hepatic Adenomas.

Authors:  Diamantis I Tsilimigras; Amir A Rahnemai-Azar; Ioannis Ntanasis-Stathopoulos; Maria Gavriatopoulou; Demetrios Moris; Eleftherios Spartalis; Jordan M Cloyd; Sharon M Weber; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-08-14       Impact factor: 3.452

3.  Multi-parameter ultrasound based on the logistic regression model in the differential diagnosis of hepatocellular adenoma and focal nodular hyperplasia.

Authors:  Meng Wu; Ru-Hai Zhou; Feng Xu; Xian-Peng Li; Ping Zhao; Rui Yuan; Yu-Peng Lan; Wei-Xia Zhou
Journal:  World J Gastrointest Oncol       Date:  2019-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.